EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children

Sarah L Downs, Courtney P Olwagen, Lara Van Der Merwe, Susan A Nzenze, Marta C Nunes, Shabir A Madhi

International Journal of Infectious Diseases · 2023

DOI: 10.1016/j.ijid.2023.05.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Infectious Diseases, 2023. Verfasst von Sarah L Downs und 5 weiteren Autor:innen. Beteiligte Einrichtung: South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Faculty of Health Sc…. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Pneumococcal Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, University of the Witwatersrand, Johannesburg, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Pneumococcal conjugate vaccines (PCVs) reduce pneumococcal-associated disease by reducing vaccine-serotype (VT) acquisition in vaccinated children, thereby interrupting VT transmission. The 7-valent-PCV was introduced in the South African immunization program in 2009 (13-valent-PCV since 2011) using a 2+1 schedule (at 6, 14, and 40 weeks of age). We aimed to evaluate temporal changes in VT and non-vaccine-serotype (NVT) colonization after 9 years of childhood PCV immunization in South Africa. METHODS: Nasopharyngeal swabs were collected from healthy children

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaePneumococcal InfectionsChildHumansInfantChild, PreschoolVaccines, ConjugateSouth AfricaCarrier StatePneumococcal VaccinesNasopharynxPrevalence

Stichwörter der Autor:innen

19FColonizationDensityPneumococcal conjugate vaccinePneumococcusSerotyping

Substanzen

Vaccines, ConjugatePneumococcal Vaccines

Autor:innen und Institutionen

  • South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Faculty of Health Science, Johannesburg, South Africa; Department of Science/ National Res…
  • South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Faculty of Health Science, Johannesburg, South Africa; Division of Public Health Surveilla…

Förderung

  • South African Medical Research Council
  • University of the Witwatersrand, Johannesburg
  • Bill and Melinda Gates Foundation
  • Department of Science and Technology, Ministry of Science and Technology, India
  • National Research Foundation

Zitieren

APA

Downs, S. L., Olwagen, C. P., Van Der Merwe, L., Nzenze, S. A., Nunes, M. C., & Madhi, S. A. (2023). Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.05.016

Vancouver

Downs SL, Olwagen CP, Van Der Merwe L, Nzenze SA, Nunes MC, Madhi SA. Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children. International Journal of Infectious Diseases. 2023. doi:10.1016/j.ijid.2023.05.016

BibTeX
@article{Downs2023,
  author = {Downs, Sarah L and Olwagen, Courtney P and Van Der Merwe, Lara and Nzenze, Susan A and Nunes, Marta C and Madhi, Shabir A},
  title = {Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children},
  journal = {International Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1016/j.ijid.2023.05.016}
}
Kostenlos starten →